Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The 56 Point TA; Charts With an Attitude -- Ignore unavailable to you. Want to Upgrade?

To: Doug R who wrote (25362)	1/13/1999 8:05:00 AM
From: Bob Biersack	Respond to of 79298

Doug...did avg on MLIN ...see HNV Thanks! Looks like a crusher of a day!! clawing my way ...Tuned In! bobcat

To: Doug R who wrote (25362)	1/13/1999 9:18:00 AM
From: Instock	Respond to of 79298

BLSC : Yes!!! " Bio-Logic Systems Corp. Awarded Largest Contract in Company's History " MUNDELEIN, Ill., Jan. 13 /PRNewswire/ -- Bio-logic Systems Corp. (Nasdaq: BLSC - news), a designer and marketer of computerized medical electro- diagnostic equipment, today announced that it has been awarded a contract by Boston Children's Hospital worth approximately $1.4 million. The contract encompasses the purchase of Bio-logic's comprehensive family of neurodiagnostic systems including long-term epilepsy monitoring, clinical EEG, ambulatory EEG, polysomnography, and intraoperative evoked potential monitoring as well as reader stations in multiple locations. Under the contract, Bio-logic will provide a state-of-the-art, integrated clinical neurophysiology laboratory. The clinical neurophysiology laboratory installation combines laboratory, portable and home monitoring systems, all networked to provide convenient access to patient records from multiple locations in order to maximize efficiency and quality of patient care. Boston Children's Hospital is affiliated with Harvard Medical School and is considered to be one of the premier pediatric neurology centers in the country. Bio-logic was one of several companies competing for this contract. ''Our company was founded on the idea that our systems should be expandable to perform more than one type of test and that these tests should be upgradeable so that our customers can cost-effectively increase their capabilities,'' said Dr. Israel Raz, Bio-logic Systems Corp. marketing director. ''Boston Children's selection of Bio-logic affirms that we are taking the right approach, utilizing the best technology.'' Bio-logic Systems Corp., headquartered in Mundelein, Ill., designs, develops, assembles and markets computer-based electro-diagnostic systems for use by hospitals, clinics, universities and physicians. The systems conduct tests that are typically used by medical practitioners to aid in the diagnosis of certain neurological, psychiatric and sensory disorders, psychological and learning disorders, brain disorders and tumors. Except for descriptions of historical facts, this release contains forward-looking statements that involve known and unknown risks, which may cause the company's actual results in the future to differ materially from those currently anticipated. These risks include, among others, fluctuations in sales and operating results; risk associated with international operations including monetary crisis; regulatory, competitive, and contractual risks; the effects of economic conditions; and the availability of capital to finance planned growth, as well as other risks detailed from time to time in the company's filings with the Securities and Exchange Commission. SOURCE: Bio-logic Systems Corp. Instock